ID   IARC-176B
AC   CVCL_A2XI
SY   IARC 176B; IARC/176B; IARC/176 B; IARC176B
DR   Wikidata; Q105509577
RX   PubMed=3934070;
RX   PubMed=6087353;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C147 ! BL-37
OI   CVCL_VQ32 ! BL-39
OI   CVCL_IV05 ! IARC-176A
OI   CVCL_VQ22 ! IARC-303A
OI   CVCL_A2XH ! IARC-303B
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 05-10-23; Version: 5
//
RX   PubMed=3934070;
RA   Lenoir G.M., Vuillaume M., Bonnardel C.;
RT   "The use of lymphomatous and lymphoblastoid cell lines in the study of
RT   Burkitt's lymphoma.";
RL   IARC Sci. Publ. 60:309-318(1985).
//
RX   PubMed=6087353; DOI=10.1073/pnas.81.15.4930; PMCID=PMC391606;
RA   Bornkamm G.-W., von Knebel-Doeberitz M., Lenoir G.M.;
RT   "No evidence for differences in the Epstein-Barr virus genome carried
RT   in Burkitt lymphoma cells and nonmalignant lymphoblastoid cells from
RT   the same patients.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:4930-4934(1984).
//